Business Description
CareDx Inc
NAICS : 325413
SIC : 8071
Description
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. Its primary operations are in Brisbane, California; Omaha, Nebraska; Fremantle, Australia and Stockholm, Sweden.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 7.52 | |||||
| Equity-to-Asset | 0.79 | |||||
| Debt-to-Equity | 0.09 | |||||
| Debt-to-EBITDA | -0.64 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 1/9 | |||||
| Altman Z-Score | 2.28 | |||||
| Beneish M-Score | -2.88 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 26 | |||||
| 3-Year EBITDA Growth Rate | -40.6 | |||||
| 3-Year EPS without NRI Growth Rate | -40.4 | |||||
| 3-Year FCF Growth Rate | -85.8 | |||||
| 3-Year Book Growth Rate | 51.2 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 24.63 | |||||
| 9-Day RSI | 30.33 | |||||
| 14-Day RSI | 33.8 | |||||
| 6-1 Month Momentum % | -7.8 | |||||
| 12-1 Month Momentum % | -60.71 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.1 | |||||
| Quick Ratio | 4.85 | |||||
| Cash Ratio | 3.86 | |||||
| Days Inventory | 59.58 | |||||
| Days Sales Outstanding | 75.31 | |||||
| Days Payable | 39.94 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -8 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 65.13 | |||||
| Operating Margin % | -24 | |||||
| Net Margin % | -23.81 | |||||
| ROE % | -17.14 | |||||
| ROA % | -13.97 | |||||
| ROIC % | -39.87 | |||||
| ROC (Joel Greenblatt) % | -98.38 | |||||
| ROCE % | -16.27 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.56 | |||||
| PB Ratio | 1.16 | |||||
| Price-to-Tangible-Book | 1.43 | |||||
| EV-to-EBIT | -3.09 | |||||
| EV-to-EBITDA | -3.89 | |||||
| EV-to-Revenue | 0.74 | |||||
| EV-to-Forward-Revenue | 0.72 | |||||
| EV-to-FCF | -4.86 | |||||
| Price-to-Projected-FCF | 4.78 | |||||
| Price-to-Net-Current-Asset-Value | 1.82 | |||||
| Price-to-Net-Cash | 2.77 | |||||
| Earnings Yield (Greenblatt) % | -32.36 |
How CareDx Inc (CDNA) Makes Its Money
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CDNA
Peter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
Executives
Details
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 321.793 | ||
| EPS (TTM) ($) | -1.44 | ||
| Beta | 1.06 | ||
| Volatility % | 65.32 | ||
| 14-Day RSI | 33.8 | ||
| 14-Day ATR ($) | 1.092749 | ||
| 20-Day SMA ($) | 11.6345 | ||
| 12-1 Month Momentum % | -60.71 | ||
| 52-Week Range ($) | 8.1 - 41.5 | ||
| Shares Outstanding (Mil) | 53.67 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CareDx Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
CareDx Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
CareDx Inc Frequently Asked Questions
What is CareDx Inc(CDNA)'s stock price today?
The current price of CDNA is $9.36. The 52 week high of CDNA is $41.50 and 52 week low is $8.10.
When is next earnings date of CareDx Inc(CDNA)?
The next earnings date of CareDx Inc(CDNA) is 2023-05-05 Est..
Does CareDx Inc(CDNA) pay dividends? If so, how much?
CareDx Inc(CDNA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
